AUSTIN, Texas, Dec. 19, 2024 /PRNewswire/ -- Alafair Biosciences announced today that it has surpassed 22,000 patient implants of its flagship product, VersaWrap Hydrogel Sheet, marking a significant ...

Alafair Biosciences, Inc., a privately held medical device company, announced that its flagship product, VersaWrap Hydrogel Sheet (VersaWrap), has been awarded a national group purchasing agreement ...

VersaWrap is an FDA-cleared medical device implant (not tissue) comprising hyaluronic acid (HA) and alginate that provides a gelatinous encasement for peripheral nerves, tendons, and surrounding ...

AUSTIN, Texas, Nov. 21, 2023 /PRNewswire/ -- Alafair Biosciences, Inc., a commercial-stage medical device company, announced that surgeons have implanted over 12,000 units of its flagship product, ...

AUSTIN, Texas, March 5, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a leading innovator in medical device technology, announced business results for 2024, marking a year of growth and expansion.

AUSTIN, Texas, Oct. 4, 2022 /PRNewswire/ -- Alafair Biosciences, Inc., a commercial-stage medical device company, announced that sales of its flagship product, VersaWrap®, have now exceeded 5000 units ...

AUSTIN, Texas--(BUSINESS WIRE)--Alafair Biosciences Inc., an emerging medical device company, announced today that it received 510(k) clearance from the FDA to market and sell its tendon product, ...

AUSTIN, Texas, June 25, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a leading innovator in medical device technology, is pleased to announce the first patient enrolled at UC Davis Foot and Ankle ...

AUSTIN, Texas, Dec. 19, 2024 /PRNewswire/ -- Alafair Biosciences announced today that it has surpassed 22,000 patient implants of its flagship product, VersaWrap Hydrogel Sheet, marking a significant ...

AUSTIN, Texas, July 2, 2024 /PRNewswire/ -- Alafair Biosciences, Inc., is revolutionizing soft tissue protection with innovative hydrogel medical devices, today announced that its flagship product, ...